Metabolic and Cardiovascular Effects of Combined Treatment with Dapagliflozin andZinc Supplementation in Metabolic Syndrome

pp. 310-315

Authors

  • Analia Tomat Chair of Physiology. School of Pharmacy and Biochemistry. Universidad de Buenos Aires. Institute of Chemistry and Drug Metabolism (IQUIMEFA), UBA-CONICET https://orcid.org/0000-0001-5575-5265
  • Rosana Elesgaray Chair of Physiology. School of Pharmacy and Biochemistry. Universidad de Buenos Aires. Institute of Chemistry and Drug Metabolism (IQUIMEFA), UBA-CONICET https://orcid.org/0000-0002-0559-0965
  • Carolina Caniffi Chair of Physiology. School of Pharmacy and Biochemistry. Universidad de Buenos Aires. Institute of Chemistry and Drug Metabolism (IQUIMEFA), UBA-CONICET https://orcid.org/0000-0002-0559-0965
  • Mariana Romero Chair of Physiology. School of Pharmacy and Biochemistry. Universidad de Buenos Aires. Institute of Chemistry and Drug Metabolism (IQUIMEFA), UBA-CONICET https://orcid.org/0009-0006-6138-5620
  • Tamara Zaobornyj Chair of Physical Chemistry, Department of Analytical Chemistry and Physical Chemistry, School of Pharmacy and Biochemistry, University of Buenos Aires. Institute of Biochemistry and Molecular Medicine (IBIMOL), UBA-CONICET. https://orcid.org/0000-0002-4310-733X
  • Cristina Arranz Chair of Physiology. School of Pharmacy and Biochemistry. Universidad de Buenos Aires. Institute of Chemistry and Drug Metabolism (IQUIMEFA), UBA-CONICET https://orcid.org/0000-0002-4149-310X

DOI:

https://doi.org/10.7775/rac.es.v94.i4.21024

Published

2026-08-28

Issue

Section

HIPOTESIS DE INVESTIGACIÓN

Most read articles by the same author(s)